<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Metousis A</submitter><funding>NCI NIH HHS</funding><pubmed_abstract>High-grade serous carcinoma (HGSC) is the most common ovarian cancer subtype, typically diagnosed at late stages with poor prognosis. Understanding early molecular events driving HGSC progression is crucial for timely detection and development of effective treatment strategies. We performed and integrated spatial cell-type resolved proteomics and paired transcriptomics across 25 women with precursor lesions of the fallopian tube and/or HGSC. Epithelial cell signatures revealed early activation of SUMOylation machinery, increased ATR and Wnt signaling, and enhanced MHC-I antigen presentation along the disease trajectory. The stroma exhibited extracellular matrix remodeling and interferon-mediated inflammation. Serous tubal intraepithelial carcinomas (STICs) in cancer patients contained a pr</pubmed_abstract><journal>medRxiv : the preprint server for health sciences</journal><pagination>2025.08.25.25333715</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12407665</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer.</pubmed_title><pmcid>PMC12407665</pmcid><funding_grant_id>R35 CA264619</funding_grant_id><pubmed_authors>Richter S</pubmed_authors><pubmed_authors>Metousis A</pubmed_authors><pubmed_authors>Lengyel E</pubmed_authors><pubmed_authors>Ben-Moshe S</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Samantaray T</pubmed_authors><pubmed_authors>Theis FJ</pubmed_authors><pubmed_authors>Kelliher L</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Mann M</pubmed_authors><pubmed_authors>Krishnan R</pubmed_authors><pubmed_authors>Yamada SD</pubmed_authors><pubmed_authors>Rosenberger FA</pubmed_authors><pubmed_authors>Nordmann TM</pubmed_authors><pubmed_authors>Kenny HA</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Ravi M</pubmed_authors><pubmed_authors>Shimizu A</pubmed_authors><pubmed_authors>Steigerwald S</pubmed_authors><pubmed_authors>Alcazar I</pubmed_authors><pubmed_authors>Bilecz A</pubmed_authors><pubmed_authors>Lastra R</pubmed_authors><pubmed_authors>Schweizer L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer.</name><description>High-grade serous carcinoma (HGSC) is the most common ovarian cancer subtype, typically diagnosed at late stages with poor prognosis. Understanding early molecular events driving HGSC progression is crucial for timely detection and development of effective treatment strategies. We performed and integrated spatial cell-type resolved proteomics and paired transcriptomics across 25 women with precursor lesions of the fallopian tube and/or HGSC. Epithelial cell signatures revealed early activation of SUMOylation machinery, increased ATR and Wnt signaling, and enhanced MHC-I antigen presentation along the disease trajectory. The stroma exhibited extracellular matrix remodeling and interferon-mediated inflammation. Serous tubal intraepithelial carcinomas (STICs) in cancer patients contained a pr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-04-25T03:16:33.25Z</modification><creation>2026-04-25T03:15:14.035Z</creation></dates><accession>S-EPMC12407665</accession><cross_references><pubmed>40909841</pubmed><doi>10.1101/2025.08.25.25333715</doi></cross_references></HashMap>